Scientists from the University of Sheffield in the UK have identified new messenger molecules shuttled between cells which could help to protect the survival of neurones potentially leading to new treatments for Motor Neurone Disease (MND).
MND or Amyotrophic Lateral Sclerosis (ALS) is a neurological disorder in which the nerve cells -- neurones -- controlling the muscles that enable us to move, speak, breathe and swallow undergo degeneration and die.
The disorder affects 5,000 adults in the UK and there is currently no cure.
The pioneering research has discovered the role of a small molecule which can regulate large signalling cascades and significantly improve the survival of neurones something which will help pave the way to identify and develop new therapies for neuro-degenerative diseases.
Approximately 10 per cent of the MND cases are inherited. The remaining 90 per cent cases are caused by complex genetic and environmental interactions, which are currently not well understood.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
